Vivoryon Therapeutics N.V. (LON: 0R3M)
London
· Delayed Price · Currency is GBP · Price in EUR 2.000
-0.030 (-1.48%)
Jan 23, 2025, 9:22 AM BST
Vivoryon Therapeutics Revenue
Vivoryon Therapeutics had revenue of -3.62M EUR in the twelve months ending June 30, 2024. In the year 2023, Vivoryon Therapeutics had annual revenue of -3.62M.
Revenue
-3.62M EUR
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
-241.33K EUR
Employees
15
Market Cap
44.75M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |